National Resilience and Taiwan Bio-Manufacturing enter into strategic manufacturing partnership

San Diego, California and Taipei, Taiwan - National Resilience (Resilience), a technology-focused biomanufacturing company, and Taiwan Bio-Manufacturing Corporation (TBMC) entered into a strategic a strategic alliance whereby TBMC will gain access to Resilience’s expertise in biologics, vaccines, nucleic acids, cell therapy and gene therapy in exchange for TBMC’s smart manufacturing and automation capabilities.

As part of the collaboration, Resilience will license certain manufacturing technology platforms in all five of its therapeutic modalities to TBMC and will provide support in designing and constructing cGMP (current Good Manufacturing Practices) facilities and process development laboratories for the joint venture. In return, Resilience will become an equity shareholder of TBMC, fostering a partnership to develop advanced manufacturing technologies for complex modalities and drive innovation in the industry.